NHMRC is collaborating with other research groups to investigate the role of screening for key pain-related outcomes and emerging problems with pharmaceutical opioids in community pharmacy practices, with the results due for release in Mar 2019.
"Community pharmacists represent an understudied and highly skilled group of health professionals that have an important role to play in addressing pharmaceutical opioid related problems," researchers say.
This project aims to evaluate "a pilot model of care which will include the development of unique pharmacy software that will enable tablet (iPad) based screening and referral.
"Those with chronic pain are prevalent in mortality data, yet little focus has been placed on changing policy and practice to respond to their treatment needs."
Details at ndarc.med.unsw.edu.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 18
